Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Soft Tissue Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05026736
What this trial is testing

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Who this might be right for
Locally Advanced AngiosarcomaMetastatic AngiosarcomaRecurrent Angiosarcoma
M.D. Anderson Cancer Center 6
Very early researchWithdrawnNCT04877587
What this trial is testing

Gemcitabine With Ascorbate Including Adolescents

Who this might be right for
Soft Tissue SarcomaBone SarcomaUnresectable Soft Tissue Sarcoma+3 more
David Dickens
Testing effectiveness (Phase 2)Ended earlyNCT03660930
What this trial is testing

Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced Soft Tissue SarcomaMetastatic Soft Tissue Sarcoma
University of Washington 19
Testing effectiveness (Phase 2)Study completedNCT01259375
What this trial is testing

Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Utah 24
Testing effectiveness (Phase 2)Ended earlyNCT04579757
What this trial is testing

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorColorectal CancerNeuroendocrine Tumors+4 more
Hutchmed 87
Testing effectiveness (Phase 2)Study completedNCT01574716
What this trial is testing

Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation

Who this might be right for
Metastatic Soft Tissue Sarcoma
Morphotek 209
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Not applicableUnknownNCT00514345
What this trial is testing

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Who this might be right for
Chemotherapeutic Agent ToxicitySarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group 300
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT04874311
What this trial is testing

Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
Institut Bergonié 80
Testing effectiveness (Phase 2)Study completedNCT00643565
What this trial is testing

Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Who this might be right for
Sarcoma
Hoffmann-La Roche 154
Testing effectiveness (Phase 2)Active Not RecruitingNCT04028063
What this trial is testing

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

Who this might be right for
Metastatic Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma
University of Colorado, Denver 65
Testing effectiveness (Phase 2)Study completedNCT02303262
What this trial is testing

SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

Who this might be right for
Metastatic Leiomyosarcoma
Sarcoma Alliance for Research through Collaboration 20
Very early researchActive Not RecruitingNCT04634227
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
University of Iowa 30
Not applicableStudy completedNCT05835154
What this trial is testing

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

Who this might be right for
Metastatic SarcomaSarcoma
Fred Hutchinson Cancer Center 27
Early research (Phase 1)Study completedNCT01643278
What this trial is testing

Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Gastrointestinal Stromal TumorStage III Soft Tissue SarcomaStage IV Soft Tissue Sarcoma
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Testing effectiveness (Phase 2)Study completedNCT00003778
What this trial is testing

Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

Who this might be right for
Ovarian CancerSarcoma
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Next Page